Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001091818-22-000145
Filing Date
2022-11-02
Accepted
2022-11-02 11:36:19
Documents
36
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 QTR. REPORT - SEPTEMBER 30, 2022 bfnh-20220930.htm   iXBRL 10-Q 234296
2 CERTIFICATION ex311.htm EX-31.1 4757
3 CERTIFICATION ex312.htm EX-31.2 4952
4 CERTIFICATION ex321.htm EX-32.1 2020
5 CERTIFICATION ex322.htm EX-32.2 1932
11 bfnhlogo2019001.jpg GRAPHIC 27243
  Complete submission text file 0001091818-22-000145.txt   1478962

Data Files

Seq Description Document Type Size
6 bfnh-20220930.xsd EX-101.SCH 22334
7 bfnh-20220930_cal.xml EX-101.CAL 13684
8 bfnh-20220930_lab.xml EX-101.LAB 169812
9 bfnh-20220930_pre.xml EX-101.PRE 70369
10 bfnh-20220930_def.xml EX-101.DEF 64304
30 EXTRACTED XBRL INSTANCE DOCUMENT bfnh-20220930_htm.xml XML 71918
Mailing Address 2020 GENERAL BOOTH BLVD SUITE 230 VIRGINIA BEACH VA 23454
Business Address 2020 GENERAL BOOTH BLVD SUITE 230 VIRGINIA BEACH VA 23454 757-306-6090
BIOFORCE NANOSCIENCES HOLDINGS, INC. (Filer) CIK: 0001310488 (see all company filings)

EIN.: 852138858 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-51074 | Film No.: 221352854
SIC: 3826 Laboratory Analytical Instruments